| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
- and ß-Chains of the IFN-
Receptor, and Triggers IFN--Mediated Apoptosis of Activated Human T Lymphocytes1
,
*
Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy;
Division of Life Sciences, Cell Growth Regulation Laboratory, King’s College, London, United Kingdom; and
Department of Medicine, G. D’Annunzio University, Chieti, Italy
In this paper, the effects of ß-galactoside binding protein
(ßGBP), the LGALS1 gene product, on the cell cycle
progression and expansion of activated human T lymphocytes were
studied. ßGBP drastically inhibits the IL-2 induced proliferation of
PHA-activated T lymphocytes as well as the IL-2 independent
proliferation of malignant T lymphocytes by arresting them in the S and
G2/M phases of the cell cycle. In addition, ßGBP
up-regulates the expression of both the 
- and the ß-chains of the
IFN-
R on activated T lymphocyte membrane. None of these effects
depend on sugar binding: saturating amounts of lactose do not affect
the cell cycle block nor IFN-R up-modulation. The increased
expression of both chains renders ßGBP-treated T lymphoblasts
sensitive to IFN--induced apoptosis. Taken as a whole, these
findings suggest that ßGBP plays an important immunoregulatory role
by switching off T lymphocyte effector functions. They also provide the
first evidence of up-modulation of IFN-R expression on T lymphocytes
by a negative cell growth regulator.
This article has been cited by other articles:
|
|
 |
|
  J. Kubach, P. Lutter, T. Bopp, S. Stoll, C. Becker, E. Huter, C. Richter, P. Weingarten, T. Warger, J. Knop, et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function Blood, September 1, 2007; 110(5): 1550 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Demers, K. Biron-Pain, J. Hebert, A. Lamarre, T. Magnaldo, and Y. St-Pierre Galectin-7 in Lymphoma: Elevated Expression in Human Lymphoid Malignancies and Decreased Lymphoma Dissemination by Antisense Strategies in Experimental Model Cancer Res., March 15, 2007; 67(6): 2824 - 2829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Camby, M. Le Mercier, F. Lefranc, and R. Kiss Galectin-1: a small protein with major functions Glycobiology, November 1, 2006; 16(11): 137R - 157R. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Li, R. Guo, W. Li, J. Shao, S. Li, K. Zhao, X. Chen, N. Xu, S. Liu, and Y. Lu A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide Carcinogenesis, June 1, 2006; 27(6): 1222 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Stowell, M. Dias-Baruffi, L. Penttila, O. Renkonen, A. K. Nyame, and R. D. Cummings Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides Glycobiology, February 1, 2004; 14(2): 157 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bernabei, M. Bosticardo, G. Losana, G. Regis, F. Di Paola, S. De Angelis, M. Giovarelli, and F. Novelli IGF-1 down-regulates IFN-{gamma}R2 chain surface expression and desensitizes IFN-{gamma}/STAT-1 signaling in human T lymphocytes Blood, October 15, 2003; 102(8): 2933 - 2939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Rabinovich, N. Rubinstein, and L. Fainboim Unlocking the secrets of galectins: a challenge at the frontier of glyco-immunology J. Leukoc. Biol., May 1, 2002; 71(5): 741 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Almkvist, C. Dahlgren, H. Leffler, and A. Karlsson Activation of the Neutrophil Nicotinamide Adenine Dinucleotide Phosphate Oxidase by Galectin-1 J. Immunol., April 15, 2002; 168(8): 4034 - 4041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Goldring, G. E. Jones, R. Thiagarajah, and D. J. Watt The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro J. Cell Sci., January 15, 2002; 115(2): 355 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bernabei, E. M. Coccia, L. Rigamonti, M. Bosticardo, G. Forni, S. Pestka, C. D. Krause, A. Battistini, and F. Novelli Interferon-{gamma} receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death J. Leukoc. Biol., December 1, 2001; 70(6): 950 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zuniga, G. A. Rabinovich, M. M. Iglesias, and A. Gruppi Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis J. Leukoc. Biol., July 1, 2001; 70(1): 73 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Chung, V. P. Patel, M. Moran, L. A. Lewis, and M. C. Miceli Galectin-1 Induces Partial TCR {zeta}-Chain Phosphorylation and Antagonizes Processive TCR Signal Transduction J. Immunol., October 1, 2000; 165(7): 3722 - 3729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rigamonti, S. Ariotti, G. Losana, R. Gradini, M. A. Russo, E. Jouanguy, J.-L. Casanova, G. Forni, and F. Novelli Surface Expression of the IFN-{gamma}R2 Chain Is Regulated by Intracellular Trafficking in Human T Lymphocytes J. Immunol., January 1, 2000; 164(1): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Allione, P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli Nitric Oxide Suppresses Human T Lymphocyte Proliferation Through IFN-{gamma}-Dependent and IFN-{gamma}-Independent Induction of Apoptosis J. Immunol., October 15, 1999; 163(8): 4182 - 4191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Rabinovich, G. Daly, H. Dreja, H. Tailor, C. M. Riera, J. Hirabayashi, and Y. Chernajovsky Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-induced Arthritis via T Cell Apoptosis J. Exp. Med., August 2, 1999; 190(3): 385 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-Y. Yang, D. K. Hsu, L. Yu, J. Ni, and F.-T. Liu Cell Cycle Regulation by Galectin-12, a New Member of the Galectin Superfamily J. Biol. Chem., June 1, 2001; 276(23): 20252 - 20260. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
